Endocrine Abstracts

Sports authorities prohibited the use of EPO in 1988 and at present any analogue or mimetic is also included in the list of prohibited substances from the World Anti-Doping Agency (WADA). The presentation will summarize the main analytical strategies developed to identify the presence of recombinant erythropoietin (EPO) administered as a doping agent.Indirect evidence is based on the analysis of blood parameters (haemoglobin, haematocrit, reticulocytes, ...